Fredun Pharmaceuticals Soars to All-Time High, Signaling Unprecedented Growth and Market Dominance

Fredun Pharmaceuticals has reached an all-time high today, October 21, 2025, with its stock price hitting Rs. 1682. This significant milestone reflects the company's robust performance in the pharmaceuticals and biotechnology sector. Over the past four days, Fredun Pharmaceuticals has shown a remarkable upward trend, gaining 13.66% during this period and outperforming its sector by 0.8% today.
The stock opened with a gain of 2.06% and achieved an intraday high of Rs. 1682, marking a 2.61% increase. In contrast, the stock's intraday low was Rs. 1575, which represents a decline of 3.92%. Fredun Pharmaceuticals has consistently traded above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong momentum.

In terms of performance metrics, the company has delivered impressive returns, with a 128.59% increase over the past year, significantly outpacing the BSE500's 3.94% return. The company's net sales have also shown substantial growth, with a quarterly increase of 52.06%, alongside a notable rise in operating profit. This all-time high underscores Fredun Pharmaceuticals' strong market position and financial health.